Pharmacogenomics Education within Nurse Anesthesia Programs and Implications for the Anesthesia Provider

Overview

About this study

The primary aim is to assess current pharmacogenomics education within nurse anesthesia programs.

A secondary aim is to provide educational recommendations on pharmacogenomics and its implications in anesthesia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

All participants must be program directors of nurse anesthesia programs currently accredited by the Council of Accreditation of Nurse Anesthesia Educational Programs.

Exclusion Criteria

Nurse anesthesia programs not accredited by the Council of Accrediation

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Wayne Nicholson, M.D., Pharm.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Wayne Nicholson, M.D., Pharm.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials